Which types of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis?

J Gastroenterol Hepatol. 2004 Jan;19(1):13-7. doi: 10.1111/j.1440-1746.2004.03189.x.

Abstract

Background and aims: Because non-bleeding visible vessels (NBVV) of gastric peptic ulcers have the potential to re-bleed, endoscopic hemostatic treatment may be necessary during the first emergency endoscopy. However, not all NBVV re-bleed, and endoscopic hemostasis sometimes causes fatal side-effects. Therefore, we have evaluated the risk of re-bleeding from various NBVV in gastric peptic ulcers to determine which types should be treated by endoscopy to prevent re-bleeding.

Methods: A total of 227 NBVV in 202 patients with gastric peptic ulcers that were endoscopically followed without endoscopic hemostatic procedures were classified by the following factors: vessel color, form, location of the NBVV in the ulcer crater, and location of the ulcer in the stomach. The re-bleeding rate was then analyzed for each type of NBVV.

Results: Significantly high rates of re-bleeding were observed in cases with white, protruded and peripheral NBVV. In particular, white NBVV located in the peripheral zone of the ulcer crater were frequent re-bleeding sources. The location of the ulcer in the stomach was not a statistically significant factor in determining re-bleeding rates.

Conclusion: We found that white, protruded and peripherally located NBVV in gastric ulcers have a higher chance of re-bleeding if preventive endoscopic hemostatic procedures are not performed.

MeSH terms

  • Chi-Square Distribution
  • Female
  • Hemostasis, Endoscopic*
  • Humans
  • Male
  • Middle Aged
  • Peptic Ulcer Hemorrhage / prevention & control*
  • Recurrence
  • Treatment Outcome